Log In
Print
BCIQ
Print
Print this Print this
 

Targin, oxycodone/naloxone (Targiniq ER)

  Manage Alerts
Collapse Summary General Information
Company Mundipharma International Ltd.
DescriptionAbuse-deterrent, extended-release/long-acting combination of oxycodone and naloxone
Molecular Target Kappa opioid receptor (OPRK1) (KOR) ; Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today